Kiniksa Pharmaceuticals International, plc (KNSA)
Pharmaceutical Preparations · Healthcare · $4.3B
Intrinsic Value (Consensus)
$15.12
Current Price
$52.30
Margin of Safety
-71.1%
71.1% Above Intrinsic Value
Value: $15
Price: $52
Valuation Model Estimates
Current Price: $52.30
DCF (Discounted Cash Flow)
$27.18
Graham Number
$11.01
Earnings Power Value
$7.28
Relative Value (P/E)
$15.00
Dividend Discount Model
Not applicable
—
Consensus Value
$15.12
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
58
Profitability
18/25
Strength
17/25
Valuation
7/25
Growth
16/25
Key Financials
- EPS (TTM)
- $0.75
- EPS (Forward)
- $0.79
- Book Value
- $7.19
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 10.4%
- Debt/Equity
- —
- Revenue Growth
- 60.1%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance